In the past twenty years, the number of hospitals that are capable of treating kids and adolescents has dropped significantly ...

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too much weight.

A raging bull market for biotech stocks and a good story have transformed an ineffective weight loss drug into a Wall Street ...

Tune into the latest episode of STATus Report for host Alex Hogan's recap of the influential #ASH25 medical conference.

Medicine taught me how to treat disease, not how to sit with suffering”: A doctor reflects on what he learned from the loss ...

Leading efforts to translate research into treatments at the NIH had felt, for physician Josh Fessel, like the way he could ...

Patients want to know, “When should I get an mpox vaccine booster?” But the research to answer their question isn’t available ...

The rise of anti-science and anti-vaccine rhetoric has fundamentally changed the relationship between clinicians and patients.” ...

Exactly a month after it announced the removal of black box warning labels on estrogen therapy products used in menopause, the Food and Drugs ...

Congress is poised to pass the Biosecure Act after two years of incremental changes that watered down the bill’s curbs on Chinese biotechs ...

High costs, quiet-period rules, investor skepticism, and lingering safety concerns are pushing major insurers to once again ...

Study points to source of "very, very rare" cases of myocarditis and potential solutions. Myocarditis risk remains far higher ...